

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.62503964 |
| 2 | glutamate secretion (GO:0014047) | 4.01544570 |
| 3 | synaptic vesicle maturation (GO:0016188) | 3.88423986 |
| 4 | sodium ion export (GO:0071436) | 3.64870306 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 3.50018776 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.49489145 |
| 7 | regulation of ARF protein signal transduction (GO:0032012) | 3.44091146 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 3.21525225 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.17767209 |
| 10 | regulation of early endosome to late endosome transport (GO:2000641) | 3.06761950 |
| 11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05694636 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 3.01903368 |
| 13 | protein localization to endosome (GO:0036010) | 2.99305596 |
| 14 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90333208 |
| 15 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77606761 |
| 16 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70535912 |
| 17 | cerebellar granule cell differentiation (GO:0021707) | 2.67989932 |
| 18 | locomotory exploration behavior (GO:0035641) | 2.64494901 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.62193381 |
| 20 | barbed-end actin filament capping (GO:0051016) | 2.53523817 |
| 21 | positive regulation of protein dephosphorylation (GO:0035307) | 2.49859860 |
| 22 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.49083318 |
| 23 | signal complex assembly (GO:0007172) | 2.48282246 |
| 24 | L-amino acid import (GO:0043092) | 2.47536849 |
| 25 | positive regulation of receptor recycling (GO:0001921) | 2.46937471 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.46439729 |
| 27 | stress fiber assembly (GO:0043149) | 2.43338121 |
| 28 | positive regulation of fibroblast migration (GO:0010763) | 2.40468351 |
| 29 | neurotransmitter secretion (GO:0007269) | 2.38509328 |
| 30 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38103754 |
| 31 | NADH metabolic process (GO:0006734) | 2.33865777 |
| 32 | amino acid import (GO:0043090) | 2.31664840 |
| 33 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31652994 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.31259930 |
| 35 | mannose metabolic process (GO:0006013) | 2.28962973 |
| 36 | receptor recycling (GO:0001881) | 2.28762722 |
| 37 | potassium ion homeostasis (GO:0055075) | 2.28582862 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.27968557 |
| 39 | negative regulation of cell killing (GO:0031342) | 2.27968557 |
| 40 | regulation of Rap GTPase activity (GO:0032317) | 2.24094163 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.23953646 |
| 42 | ethanol oxidation (GO:0006069) | 2.20622927 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 2.20542040 |
| 44 | regulation of protein dephosphorylation (GO:0035304) | 2.19484371 |
| 45 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.18298590 |
| 46 | regulation of synaptic plasticity (GO:0048167) | 2.16069439 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 2.15620901 |
| 48 | positive regulation of extracellular matrix organization (GO:1903055) | 2.15518160 |
| 49 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.14444021 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.14186391 |
| 51 | cell communication by electrical coupling (GO:0010644) | 2.11324588 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.10280288 |
| 53 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.08402241 |
| 54 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.06321351 |
| 55 | actin filament capping (GO:0051693) | 2.05635210 |
| 56 | actin filament depolymerization (GO:0030042) | 2.05391677 |
| 57 | regulation of regulated secretory pathway (GO:1903305) | 2.03176171 |
| 58 | cellular sodium ion homeostasis (GO:0006883) | 2.03003926 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.02923359 |
| 60 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.01218560 |
| 61 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.00843324 |
| 62 | exploration behavior (GO:0035640) | 2.00397869 |
| 63 | protein targeting to plasma membrane (GO:0072661) | 1.99746263 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.99367417 |
| 65 | protein carboxylation (GO:0018214) | 1.99367417 |
| 66 | neuronal ion channel clustering (GO:0045161) | 1.99135293 |
| 67 | potassium ion import (GO:0010107) | 1.98745087 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.98592226 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 1.97593931 |
| 70 | phosphate ion transmembrane transport (GO:0035435) | 1.97572397 |
| 71 | skin morphogenesis (GO:0043589) | 1.97537851 |
| 72 | positive regulation of triglyceride lipase activity (GO:0061365) | 1.96656095 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 1.96656095 |
| 74 | virion attachment to host cell (GO:0019062) | 1.96184012 |
| 75 | adhesion of symbiont to host cell (GO:0044650) | 1.96184012 |
| 76 | positive regulation of neurotransmitter transport (GO:0051590) | 1.95743631 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 1.95471467 |
| 78 | regulation of ARF GTPase activity (GO:0032312) | 1.94685698 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 1.94421951 |
| 80 | response to parathyroid hormone (GO:0071107) | 1.93408745 |
| 81 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.93274027 |
| 82 | mating behavior (GO:0007617) | 1.93095473 |
| 83 | macroautophagy (GO:0016236) | 1.91603758 |
| 84 | dopamine receptor signaling pathway (GO:0007212) | 1.91546090 |
| 85 | hypotonic response (GO:0006971) | 1.91076891 |
| 86 | negative regulation of fibrinolysis (GO:0051918) | 1.90803320 |
| 87 | actin filament polymerization (GO:0030041) | 1.90036964 |
| 88 | neurotransmitter transport (GO:0006836) | 1.89637040 |
| 89 | cellular response to monoamine stimulus (GO:0071868) | 1.89028725 |
| 90 | cellular response to catecholamine stimulus (GO:0071870) | 1.89028725 |
| 91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.89000041 |
| 92 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.88177745 |
| 93 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 1.88176874 |
| 94 | ethanol metabolic process (GO:0006067) | 1.86155728 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 1.85974494 |
| 96 | regulation of cellular amide metabolic process (GO:0034248) | 1.85587396 |
| 97 | response to acidic pH (GO:0010447) | 1.85486877 |
| 98 | activation of protein kinase A activity (GO:0034199) | 1.84529319 |
| 99 | transferrin transport (GO:0033572) | 1.84348675 |
| 100 | cell-substrate adherens junction assembly (GO:0007045) | 1.82350756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.51899982 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48067284 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41486375 |
| 4 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.35994341 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.28085819 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12105598 |
| 7 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09063733 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00436724 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92718482 |
| 10 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.90590686 |
| 11 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84730575 |
| 12 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75457160 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74799635 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74032028 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70246356 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.68908085 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.65711362 |
| 18 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59045750 |
| 19 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58341666 |
| 20 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.55224899 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55164438 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51783672 |
| 23 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51771807 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50232248 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50189757 |
| 26 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49842866 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49408802 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48446094 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47528640 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46622150 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46379733 |
| 32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40772315 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.39652398 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36080235 |
| 35 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34463592 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34114987 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31939462 |
| 38 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.31320291 |
| 39 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30788463 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29490738 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27082966 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25118505 |
| 43 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24950722 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24188563 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23164546 |
| 46 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23046335 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22427660 |
| 48 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.21520500 |
| 49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20939271 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20638198 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19454964 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19288197 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18533349 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18106824 |
| 55 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18072826 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17868302 |
| 57 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16543522 |
| 58 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14013595 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13511237 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13453924 |
| 61 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13250897 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13128995 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12826997 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.11293818 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11273552 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11201698 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09838595 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09474487 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09118698 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07754032 |
| 71 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07551977 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07159296 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06936392 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06936392 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05931213 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05281250 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04627838 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04468374 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02857362 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02857362 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02832501 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02373622 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02308678 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02248588 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01379244 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01195334 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00601372 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00229695 |
| 89 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.99972152 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99234506 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96686907 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95565064 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94939561 |
| 94 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.94661689 |
| 95 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94470505 |
| 96 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94246294 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93877573 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92247999 |
| 99 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.91925891 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90314014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.77195612 |
| 2 | MP0004270_analgesia | 2.81706410 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.69875219 |
| 4 | MP0009840_abnormal_foam_cell | 2.68928631 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.68018515 |
| 6 | MP0003879_abnormal_hair_cell | 2.57623558 |
| 7 | MP0003329_amyloid_beta_deposits | 2.50766642 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.45869605 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.30168305 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.11903590 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.03872858 |
| 12 | MP0003303_peritoneal_inflammation | 2.01764685 |
| 13 | MP0003172_abnormal_lysosome_physiology | 1.98906139 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 1.98694217 |
| 15 | MP0003075_altered_response_to | 1.97141783 |
| 16 | MP0005409_darkened_coat_color | 1.94476841 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 1.89206926 |
| 18 | MP0005360_urolithiasis | 1.83823634 |
| 19 | MP0005365_abnormal_bile_salt | 1.78459298 |
| 20 | MP0000604_amyloidosis | 1.78244399 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 1.74949959 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.73064791 |
| 23 | MP0008260_abnormal_autophagy | 1.71997533 |
| 24 | MP0002064_seizures | 1.70991904 |
| 25 | MP0003436_decreased_susceptibility_to | 1.56424849 |
| 26 | MP0001958_emphysema | 1.55906064 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.51883308 |
| 28 | MP0008569_lethality_at_weaning | 1.51639758 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.50943064 |
| 30 | MP0003690_abnormal_glial_cell | 1.49298310 |
| 31 | MP0003880_abnormal_central_pattern | 1.44750591 |
| 32 | MP0003279_aneurysm | 1.43475585 |
| 33 | MP0004510_myositis | 1.42319197 |
| 34 | MP0004130_abnormal_muscle_cell | 1.42060573 |
| 35 | MP0005451_abnormal_body_composition | 1.39368633 |
| 36 | MP0005166_decreased_susceptibility_to | 1.38988339 |
| 37 | MP0008874_decreased_physiological_sensi | 1.34645347 |
| 38 | MP0000920_abnormal_myelination | 1.34611577 |
| 39 | MP0004858_abnormal_nervous_system | 1.34251560 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.30639853 |
| 41 | MP0002063_abnormal_learning/memory/cond | 1.30484569 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.29250409 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.24653581 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.21355152 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.14770228 |
| 46 | MP0000751_myopathy | 1.13745816 |
| 47 | MP0003091_abnormal_cell_migration | 1.13186317 |
| 48 | MP0001849_ear_inflammation | 1.13147585 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.09604504 |
| 50 | MP0002796_impaired_skin_barrier | 1.08658004 |
| 51 | MP0005275_abnormal_skin_tensile | 1.07987647 |
| 52 | MP0003724_increased_susceptibility_to | 1.07933880 |
| 53 | MP0009745_abnormal_behavioral_response | 1.07520181 |
| 54 | MP0003828_pulmonary_edema | 1.06319176 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.06141966 |
| 56 | MP0003633_abnormal_nervous_system | 1.05284639 |
| 57 | MP0001666_abnormal_nutrient_absorption | 1.02483970 |
| 58 | MP0005535_abnormal_body_temperature | 0.97292889 |
| 59 | MP0002971_abnormal_brown_adipose | 0.96555352 |
| 60 | MP0003868_abnormal_feces_composition | 0.95886948 |
| 61 | MP0002272_abnormal_nervous_system | 0.94790523 |
| 62 | MP0005165_increased_susceptibility_to | 0.94631500 |
| 63 | MP0006082_CNS_inflammation | 0.93794778 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 0.93632758 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 0.92349482 |
| 66 | MP0003123_paternal_imprinting | 0.91480945 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.89607976 |
| 68 | MP0004947_skin_inflammation | 0.89431754 |
| 69 | MP0002295_abnormal_pulmonary_circulatio | 0.89424489 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.89204059 |
| 71 | MP0003634_abnormal_glial_cell | 0.89198662 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.87292873 |
| 73 | MP0005023_abnormal_wound_healing | 0.86083318 |
| 74 | MP0001440_abnormal_grooming_behavior | 0.85345964 |
| 75 | MP0003045_fibrosis | 0.84461307 |
| 76 | MP0002132_abnormal_respiratory_system | 0.84353708 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.83684413 |
| 78 | MP0000747_muscle_weakness | 0.83592452 |
| 79 | MP0005257_abnormal_intraocular_pressure | 0.77029033 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.76342240 |
| 81 | MP0001970_abnormal_pain_threshold | 0.75106421 |
| 82 | MP0002896_abnormal_bone_mineralization | 0.74216209 |
| 83 | MP0003866_abnormal_defecation | 0.73929258 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.72975489 |
| 85 | MP0002733_abnormal_thermal_nociception | 0.72964683 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.72878482 |
| 87 | MP0003631_nervous_system_phenotype | 0.72831256 |
| 88 | MP0010155_abnormal_intestine_physiology | 0.72730413 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.72202837 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70938642 |
| 91 | MP0000858_altered_metastatic_potential | 0.70582919 |
| 92 | MP0002133_abnormal_respiratory_system | 0.70213830 |
| 93 | MP0005388_respiratory_system_phenotype | 0.70213830 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.70147993 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.70009677 |
| 96 | MP0009379_abnormal_foot_pigmentation | 0.68563212 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.68473617 |
| 98 | MP0001542_abnormal_bone_strength | 0.67757578 |
| 99 | MP0008004_abnormal_stomach_pH | 0.67084383 |
| 100 | MP0000343_altered_response_to | 0.67019161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 3.37914176 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 3.29555241 |
| 3 | Neurofibrillary tangles (HP:0002185) | 3.14811347 |
| 4 | Protrusio acetabuli (HP:0003179) | 2.93277251 |
| 5 | Myokymia (HP:0002411) | 2.82107455 |
| 6 | Ankle clonus (HP:0011448) | 2.79127739 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 2.75622424 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 2.55796012 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.51887138 |
| 10 | Deep venous thrombosis (HP:0002625) | 2.49460670 |
| 11 | Distal upper limb amyotrophy (HP:0007149) | 2.49349568 |
| 12 | Upper limb amyotrophy (HP:0009129) | 2.49349568 |
| 13 | Vascular tortuosity (HP:0004948) | 2.45908254 |
| 14 | Torticollis (HP:0000473) | 2.45260926 |
| 15 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42312584 |
| 16 | Diplopia (HP:0000651) | 2.38295439 |
| 17 | Abnormality of binocular vision (HP:0011514) | 2.38295439 |
| 18 | Arterial tortuosity (HP:0005116) | 2.35290050 |
| 19 | Dysostosis multiplex (HP:0000943) | 2.34200323 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 2.31127912 |
| 21 | Axonal loss (HP:0003447) | 2.30392545 |
| 22 | Mucopolysacchariduria (HP:0008155) | 2.29331178 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29331178 |
| 24 | Vertebral compression fractures (HP:0002953) | 2.28354063 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27328378 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27328378 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27328378 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.24962076 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.24400938 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 2.21181865 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.20794027 |
| 32 | Action tremor (HP:0002345) | 2.18896380 |
| 33 | Hyperparathyroidism (HP:0000843) | 2.17594930 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17349583 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17349583 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17349583 |
| 37 | Premature rupture of membranes (HP:0001788) | 2.17176913 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.15645867 |
| 39 | Amyloidosis (HP:0011034) | 2.14920358 |
| 40 | Craniofacial dystonia (HP:0012179) | 2.12202513 |
| 41 | Visual hallucinations (HP:0002367) | 2.11883766 |
| 42 | Focal dystonia (HP:0004373) | 2.10147749 |
| 43 | Hand muscle atrophy (HP:0009130) | 2.09925908 |
| 44 | Papilledema (HP:0001085) | 2.08876112 |
| 45 | Depression (HP:0000716) | 2.03937578 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.00509628 |
| 47 | Mutism (HP:0002300) | 2.00202865 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00112896 |
| 49 | Purpura (HP:0000979) | 1.99409879 |
| 50 | Xanthomatosis (HP:0000991) | 1.99315544 |
| 51 | Malnutrition (HP:0004395) | 1.98353464 |
| 52 | Increased connective tissue (HP:0009025) | 1.98293857 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 1.97770007 |
| 54 | Polycythemia (HP:0001901) | 1.97507752 |
| 55 | Rigidity (HP:0002063) | 1.97291696 |
| 56 | Complement deficiency (HP:0004431) | 1.95778266 |
| 57 | Abnormality of complement system (HP:0005339) | 1.95233013 |
| 58 | Hemorrhage of the eye (HP:0011885) | 1.92569776 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 1.92022823 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91987302 |
| 61 | Hypercortisolism (HP:0001578) | 1.91812154 |
| 62 | Achilles tendon contracture (HP:0001771) | 1.91013203 |
| 63 | Ventricular fibrillation (HP:0001663) | 1.90279511 |
| 64 | Aortic aneurysm (HP:0004942) | 1.89650418 |
| 65 | Exercise-induced myalgia (HP:0003738) | 1.88460418 |
| 66 | Annular pancreas (HP:0001734) | 1.87265075 |
| 67 | Postural instability (HP:0002172) | 1.86999095 |
| 68 | Abnormality of macrophages (HP:0004311) | 1.86780197 |
| 69 | Rapidly progressive (HP:0003678) | 1.86183825 |
| 70 | Muscle fiber splitting (HP:0003555) | 1.84813934 |
| 71 | Growth hormone excess (HP:0000845) | 1.84483969 |
| 72 | Mitral stenosis (HP:0001718) | 1.83318132 |
| 73 | Nuclear cataract (HP:0100018) | 1.82103370 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 1.81893822 |
| 75 | Peritonitis (HP:0002586) | 1.80949138 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 1.80347360 |
| 77 | Cervical subluxation (HP:0003308) | 1.78663680 |
| 78 | Intention tremor (HP:0002080) | 1.77883561 |
| 79 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77409512 |
| 80 | Tetraplegia (HP:0002445) | 1.77306967 |
| 81 | Hydroxyprolinuria (HP:0003080) | 1.75080645 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 1.75080645 |
| 83 | Focal motor seizures (HP:0011153) | 1.74757529 |
| 84 | Cardiovascular calcification (HP:0011915) | 1.74180185 |
| 85 | Abnormal eating behavior (HP:0100738) | 1.73514646 |
| 86 | Akinesia (HP:0002304) | 1.70744996 |
| 87 | Polygenic inheritance (HP:0010982) | 1.70518079 |
| 88 | Fragile skin (HP:0001030) | 1.69882909 |
| 89 | Dementia (HP:0000726) | 1.69359115 |
| 90 | Broad metatarsal (HP:0001783) | 1.69109954 |
| 91 | Vascular calcification (HP:0004934) | 1.68280065 |
| 92 | Glomerulonephritis (HP:0000099) | 1.67586783 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.67428292 |
| 94 | Thin bony cortex (HP:0002753) | 1.67340881 |
| 95 | Aneurysm (HP:0002617) | 1.66734541 |
| 96 | Difficulty running (HP:0009046) | 1.66536848 |
| 97 | Apathy (HP:0000741) | 1.66030213 |
| 98 | Dysmetria (HP:0001310) | 1.65485140 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.65416597 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.64487698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 2.95704754 |
| 2 | RIPK1 | 2.89389305 |
| 3 | ERN1 | 2.85212931 |
| 4 | RIPK4 | 2.68827056 |
| 5 | TRIB3 | 2.25896494 |
| 6 | EPHA4 | 2.23082366 |
| 7 | DAPK2 | 1.99251852 |
| 8 | KSR2 | 1.99150283 |
| 9 | MAP3K9 | 1.84310256 |
| 10 | PAK6 | 1.83559078 |
| 11 | ARAF | 1.80791769 |
| 12 | MAP3K11 | 1.76923082 |
| 13 | NTRK3 | 1.68849320 |
| 14 | SIK1 | 1.63241797 |
| 15 | NTRK1 | 1.56439192 |
| 16 | MAP3K3 | 1.53274625 |
| 17 | MAP3K2 | 1.50803405 |
| 18 | TESK1 | 1.48711213 |
| 19 | LMTK2 | 1.45806975 |
| 20 | MAP3K1 | 1.44771785 |
| 21 | MAP3K13 | 1.35426930 |
| 22 | PRKD3 | 1.33628788 |
| 23 | PDPK1 | 1.32833546 |
| 24 | PRKG2 | 1.30150086 |
| 25 | MARK2 | 1.29495306 |
| 26 | MAP2K3 | 1.28822746 |
| 27 | CAMKK1 | 1.28275341 |
| 28 | LATS2 | 1.26079647 |
| 29 | EPHB1 | 1.25585922 |
| 30 | STK38 | 1.21934135 |
| 31 | TAOK1 | 1.19804167 |
| 32 | TAOK2 | 1.13349148 |
| 33 | UHMK1 | 1.11556511 |
| 34 | PRKD2 | 1.10717876 |
| 35 | EPHA2 | 1.09047403 |
| 36 | GRK5 | 1.06773832 |
| 37 | MAPK12 | 1.06748160 |
| 38 | PDK1 | 1.04127563 |
| 39 | MAP3K12 | 1.02947724 |
| 40 | PTK2 | 0.97826677 |
| 41 | SGK3 | 0.95487722 |
| 42 | ICK | 0.93424524 |
| 43 | TYK2 | 0.92369095 |
| 44 | MYLK | 0.90143899 |
| 45 | TTN | 0.88074766 |
| 46 | TNK2 | 0.85114258 |
| 47 | CDC42BPA | 0.84791272 |
| 48 | BRAF | 0.84260777 |
| 49 | ZAP70 | 0.83981124 |
| 50 | PDGFRA | 0.81302095 |
| 51 | TGFBR2 | 0.80748491 |
| 52 | PRKCH | 0.80715026 |
| 53 | FES | 0.80160911 |
| 54 | CSK | 0.78188035 |
| 55 | FGFR4 | 0.77687944 |
| 56 | SGK494 | 0.76766646 |
| 57 | SGK223 | 0.76766646 |
| 58 | CAMK1 | 0.74763757 |
| 59 | CDK5 | 0.72382577 |
| 60 | SMG1 | 0.72329861 |
| 61 | PHKG1 | 0.71635228 |
| 62 | PHKG2 | 0.71635228 |
| 63 | PTK6 | 0.70820214 |
| 64 | DMPK | 0.70230623 |
| 65 | RPS6KA2 | 0.69267171 |
| 66 | MINK1 | 0.68693238 |
| 67 | GRK6 | 0.67839756 |
| 68 | TBK1 | 0.63462071 |
| 69 | IRAK3 | 0.63176450 |
| 70 | JAK1 | 0.62637015 |
| 71 | LIMK1 | 0.61236216 |
| 72 | DYRK1B | 0.61016390 |
| 73 | RET | 0.60900387 |
| 74 | SIK2 | 0.60177680 |
| 75 | STK11 | 0.58553555 |
| 76 | CDK19 | 0.58521467 |
| 77 | DAPK3 | 0.58364861 |
| 78 | BMX | 0.57760838 |
| 79 | DDR2 | 0.57482844 |
| 80 | FGFR3 | 0.57285423 |
| 81 | ABL2 | 0.56901432 |
| 82 | MAP4K1 | 0.55651432 |
| 83 | SGK2 | 0.55559195 |
| 84 | MOS | 0.54437724 |
| 85 | PAK4 | 0.53998540 |
| 86 | MAP2K1 | 0.53033768 |
| 87 | ROCK2 | 0.52622268 |
| 88 | IRAK2 | 0.51150946 |
| 89 | LRRK2 | 0.50543202 |
| 90 | EPHB2 | 0.50250519 |
| 91 | CAMK2G | 0.49922526 |
| 92 | MAP2K4 | 0.49411141 |
| 93 | JAK2 | 0.49062624 |
| 94 | MAP3K6 | 0.47654419 |
| 95 | PTK2B | 0.47456086 |
| 96 | FYN | 0.47410557 |
| 97 | SIK3 | 0.46397072 |
| 98 | KSR1 | 0.45203984 |
| 99 | TYRO3 | 0.44520183 |
| 100 | MAP2K6 | 0.44485166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28471150 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11599585 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 1.84899394 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82794866 |
| 5 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44570662 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34608524 |
| 7 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29530147 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 1.27325909 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.24258300 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.23837936 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23688799 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.20914546 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14519507 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13994638 |
| 15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13073050 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11497981 |
| 17 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10846487 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09264461 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08255481 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07832338 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04286756 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02332066 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01619300 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99849988 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98601660 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98435869 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98035616 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97363717 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 0.97076269 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 0.95134677 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94302066 |
| 32 | Glioma_Homo sapiens_hsa05214 | 0.93290295 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92567448 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92034689 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91472434 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90760731 |
| 37 | Endocytosis_Homo sapiens_hsa04144 | 0.90728689 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90562240 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88705202 |
| 40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87902079 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87820279 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87186145 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84378122 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84031917 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84026174 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80907812 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.80677469 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80574355 |
| 49 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79884528 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.78998219 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76590557 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76484686 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76323462 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76037901 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75770917 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75336497 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74723753 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73289341 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71752542 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70713689 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70061988 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69692372 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.68951017 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68617664 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67281085 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67279375 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65466180 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.65078739 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64482812 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.64337751 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.64046329 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63418426 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63041550 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62068187 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.61809856 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61786952 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61478648 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61091087 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60933736 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60909763 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60741128 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59255476 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.59024772 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58390916 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57435092 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57291186 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56934198 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55836561 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.55688767 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55321445 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55174345 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54466994 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53781043 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53487944 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52761342 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.52316175 |
| 97 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51938504 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51891080 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.51792661 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50679818 |

